Regenexx was featured in the Broomfield Enterprise . Click here for full article.
February 21, 2010
February 10, 2010
February 4, 2010
Physical examination was significant for tenderness along the patellar tendon, slight limp, muscle tightness in her lumbar spine and tenderness and pain with palpation of her sacro-illace jont. Most significant however was the instability of her knee which her husband noted from across the room. The anterior cruciate ligamant(ACL),was very loose suggestive of a tear. Review of the MRI demonstrated a chronic tear in the ACL.
The anterior cruciate ligament is one of four major ligaments in the knee. It originates from the back portion of the thigh bone( femur) and attaches to the front portion of the shin bone ( tibia). It prevents forward movement of the tibia in relation to the femur. It provides critical stability to the knee. Tears of injury to the ACL result in instability of the joint with resultant pain.
There is no substitute for a complete physical examination. MRI’s alone can not make a diagnosis. Putting the physical findings together with MRI results is the standard of care at The Centeno-Schultz Clinic.
Utilizing a patient’s own stem cells, repair of a partial tear of the ACL is possible. The Regenexx procedure affords patients the opportunity to use their own mesenchymal stem cells to treat common orthopedic conditions.
February 1, 2010
Mesenchymal stem cells can differentiate into many types of tissue including muscle, bone, cartilage and tendon.
Because mesnechymal stem cells are multipotent, there has been concern that implanted stem cells could form cancer cells.
Studies have demonstrated chromosomal abnormalities in mesenchymal stem cells that have been cultured for extended periods of time. Other studies have demonstrated that mesnenchymal stem cells expanded for less than 60 days poses no detectable risk of cell changes or cancer formation.
The critical question is whether mesenchymal stem cells are safe ?
Centeno et. a.l. have shown that they are safe.
Centeno, in a prospective study examined 227 patients and found no evidence of cancer formation at re-implantation site. This finding is consistent with others who failed to find any evidence of cancer formation in mesenchymal stem cells culture expanded for limited periods.
Landmark study. Stem cell therapy has a green light!
The Regenexx procedure utilizes minimally expanded autologous meenschymal stem cells to treat common orthopedic conditions. This affords patients a non-surgical option with no extensive rehabilitation or the risks associated with anesthesia and surgery.